Directory
>
Camillo Docimo
Camillo Docimo
Vice President Global Program Excellence and Business Development | Allurion Technologies
United States
Camillo Docimo
Summary
Camillo Docimo is an accomplished leader with over 25 years of experience in the biotechnology and medical devices sectors, specializing in obesity and metabolic surgery. Currently serving as Vice President of Global Program Excellence and Business Development at Allurion Technologies, he combines deep clinical knowledge with strategic business acumen to drive innovation and market growth. His extensive background includes key roles in international sales and marketing, where he has successfully launched new medical devices and developed scientific sales strategies. Camillo's expertise spans multiple therapeutic areas including cardiology, endocrinology, and surgical interventions, making him a valuable asset in the healthcare landscape. He is known for his strong team-building skills and ability to foster collaboration across cross-functional teams. His involvement with key opinion leaders and major international congresses highlights his commitment to advancing medical practices and education.
Camillo Docimo
Work Experience
Vice President Global Program Excellence and Business Development at
Allurion Technologies
January 2021 - Present
Director of International Sales and Marketing at
Allurion Technologies
February 2015 - December 2020
Regional Director EMEA at
Obalon Therapeutics
January 2012 - December 2014
Senior Clinical Science liaison EMEA at
AbbVie
January 2010 - December 2011
Study Manager-Regional Scientific Services Manager EMEA at
AbbVie
January 2009 - December 2010
Clinical Marketing Manager EMEA at
AbbVie
January 2007 - December 2009
Sales area manager (South Italy), EMEA Study manager at
Inamed
May 2001 - December 2006
Study manager and Clinical consultant at
Inamed
January 1999 - April 2001
Consultant at
Ethicon, Inc.
September 1996 - December 2000
Administrative officier at
European Commission
September 1994 - July 1996
Frequently Asked Questions about Camillo Docimo
What is Camillo Docimo email address?
Camillo Docimo's primary email address is *******@allurion.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Camillo Docimo work for?
Camillo Docimo is a Vice President Global Program Excellence and Business Development at Allurion Technologies, a company specializing in Medical Equipment & Supplies Manufacturing.
How can I directly contact Camillo Docimo?
To contact Camillo Docimo directly, you can use the email address *******@allurion.com. Complete contact information is available upon registration with Muraena.
Who is Camillo Docimo?
Camillo Docimo is an accomplished leader with over 25 years of experience in the biotechnology and medical devices sectors, specializing in obesity and metabolic surgery. Currently serving as Vice President of Global Program Excellence and Business Development at Allurion Technologies, he combines deep clinical knowledge with strategic business acumen to drive innovation and market growth. His extensive background includes key roles in international sales and marketing, where he has successfully launched new medical devices and developed scientific sales strategies. Camillo's expertise spans multiple therapeutic areas including cardiology, endocrinology, and surgical interventions, making him a valuable asset in the healthcare landscape. He is known for his strong team-building skills and ability to foster collaboration across cross-functional teams. His involvement with key opinion leaders and major international congresses highlights his commitment to advancing medical practices and education.
Camillo`s contact details
*******@allurion.com
**************@allergan.com
Colleagues
Co-Founder & CEO
Vice President Growth and Global Marketing
Vice President, Medical Affairs
VP Finance
Senior Vice President RA/QA
Chief Financial Officer
Specialized Ophthalmologist
Management Advisory Board member
VP of Software Engineering
VP Business Development & Innovation